INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR RETINAL ANGIOMATOUS PROLIFERATION-Reference-Cited by-同舟云学术

INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR RETINAL ANGIOMATOUS PROLIFERATION

Published:2007-04 Issue:4 Volume:27 Page:451-457
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

MEYERLE CATHERINE B.,FREUND K BAILEY,ITURRALDE DIANA,SPAIDE RICHARD F.,SORENSON JOHN A.,SLAKTER JASON S.,KLANCNIK JAMES M.,FISHER YALE L.,COONEY MICHAEL J.,YANNUZZI LAWRENCE A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference15 articles.

1. Retinal angiomatous proliferation in age-related macular degeneration.;Yannuzzi;Retina,2001

2. Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation.;Gross;Retina,2005

3. The nature of focal areas of hyperfluorescence or hot spots imaged with indocyanine green angiography.;Fernandes;Retina,2002

4. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation.;Bottoni;Arch Ophthalmol,2005

5. Retinal anastomosis to choroidal neovascularization: a bum rap for a difficult disease.;Bressler;Arch Ophthalmol,2005

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional and structural characteristics in patients with type 3 macular neovascularisation treated with anti-VEGF. Three-year results in real world settings;Eye;2024-01-06

2. Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration;Ophthalmologica;2024

3. Case Report: A Case of Perifoveal Exudative Vascular Anomalous Complex With a Good Prognosis;Frontiers in Medicine;2021-12-13

4. A proof of concept study to evaluate the treatment response of aflibercept in wARMD using OCT-A (Canada study);International Ophthalmology;2021-02-07

5. Detailed optical coherence tomography angiographic short‐term response of type 3 neovascularization to combined treatment with photodynamic therapy and intravitreal bevacizumab;Acta Ophthalmologica;2020-06-29